Thus, it is tempting to speculate that C5a might act as a potential target for immunomodulation after chest trauma [74], to avoid the deleterious effects of posttraumatic inflammation, which lead to ARDS, multiorgan failure, and death [97, 129]. The gene discussed is C5; the disease is acute respiratory distress syndrome.